Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
GlobalData on MSN19h
Senseonics files for Eversense 365 CE Mark registrationCompleting the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for ...
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Medical Center Hospital is celebrating 200 successful open-heart surgeries in 2024. The Beat Goes On will take place from 4 p ...
The Midland Health Drive Thru Testing Clinic saw 30 patients Feb. 7 with a 26% positivity rate. The clinic will be testing Feb. 8 from 9 a.m. to 1 p.m. In addition, the clinic will be open next week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback